Benefits Over Five Years of Ixekizumab Treatment in Patients With Psoriasis Involving Challenging Body Areas.
Alice B GottliebApril ArmstrongAndrew BlauveltChristopher E M GriffithsAndreas PinterMelinda GooderhamMark LomagaRussel T BurgeBruce W KonicekMeghan Feely McDonaldKyoungah SeeMissy McKean-MatthewsTomotaka MabuchiPublished in: Journal of drugs in dermatology : JDD (2024)
For most efficacy measures, patients treated with ixekizumab over 5 years achieved similar clear responses and cumulative clinical benefits regardless of baseline involvement of challenging body areas. J Drugs Dermatol. 2024;23(8):619-625. doi:10.36849/JDD.8160.
Keyphrases